Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Probing RNA structures with hydroxyl radicals.

Celander DW.

Curr Protoc Nucleic Acid Chem. 2001 May;Chapter 6:Unit 6.5. doi: 10.1002/0471142700.nc0605s00.

PMID:
18428866
2.

Novel RNA-binding properties of Pop3p support a role for eukaryotic RNase P protein subunits in substrate recognition.

Brusca EM, True HL, Celander DW.

J Biol Chem. 2001 Nov 9;276(45):42543-8. Epub 2001 Aug 29.

3.

RNA challenge phages as genetic tools for study of RNA-ligand interactions.

Celander DW, Bennett KA, Fouts DE, Seitz EA, True HL.

Methods Enzymol. 2000;318:332-50. No abstract available.

PMID:
10889997
4.
5.
6.

Functional recognition of fragmented operator sites by R17/MS2 coat protein, a translational repressor.

Fouts DE, True HL, Celander DW.

Nucleic Acids Res. 1997 Nov 15;25(22):4464-73.

7.
8.

Direct genetic selection of two classes of R17/MS2 coat proteins with altered capsid assembly properties and expanded RNA-binding activities.

Wang S, True HL, Seitz EM, Bennett KA, Fouts DE, Gardner JF, Celander DW.

Nucleic Acids Res. 1997 Apr 15;25(8):1649-57.

10.

Ribonuclease P of Tetrahymena thermophila.

True HL, Celander DW.

J Biol Chem. 1996 Jul 12;271(28):16559-66.

11.

Improved method for selecting RNA-binding activities in vivo.

Fouts DE, Celander DW.

Nucleic Acids Res. 1996 Apr 15;24(8):1582-4.

12.

Direct genetic selection for a specific RNA-protein interaction.

MacWilliams MP, Celander DW, Gardner JF.

Nucleic Acids Res. 1993 Dec 11;21(24):5754-60.

13.

Mutations at the guanosine-binding site of the Tetrahymena ribozyme also affect site-specific hydrolysis.

Legault P, Herschlag D, Celander DW, Cech TR.

Nucleic Acids Res. 1992 Dec 25;20(24):6613-9.

14.

Folding of group I introns from bacteriophage T4 involves internalization of the catalytic core.

Heuer TS, Chandry PS, Belfort M, Celander DW, Cech TR.

Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11105-9.

15.
16.

Visualizing the higher order folding of a catalytic RNA molecule.

Celander DW, Cech TR.

Science. 1991 Jan 25;251(4992):401-7.

PMID:
1989074
18.

Two versions of the gene encoding the 41-kilodalton subunit of the telomere binding protein of Oxytricha nova.

Hicke BJ, Celander DW, MacDonald GH, Price CM, Cech TR.

Proc Natl Acad Sci U S A. 1990 Feb;87(4):1481-5.

19.

Rapid procedure for chemical sequencing of small oligonucleotides without ethanol precipitation.

Williamson JR, Celander DW.

Nucleic Acids Res. 1990 Jan 25;18(2):379. No abstract available.

20.
22.
23.

Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat.

Lenz J, Celander D, Crowther RL, Patarca R, Perkins DW, Haseltine WA.

Nature. 1984 Mar 29-Apr 4;308(5958):467-70.

PMID:
6323995
24.

Coagulation and fibrinolysis in neoplasia: clinical assessment and experiment models.

Pratt HW 2nd, Louvar RD, Celander DR.

J Am Osteopath Assoc. 1971 Jun;70(10):1107-8. No abstract available.

PMID:
5207163
25.

Nature of incorporation of radioactive selenium into proteins of canine erythrocytes.

Celander DR, Pipkin GE, Kelley B, Gordon LG, Celander E.

J Am Osteopath Assoc. 1971 Jun;70(10):1098-102. No abstract available.

PMID:
5207161
26.

[In vitro blood coagulation and immunoelectrophoretic studies using irradiated and unirradiated protein-free blood extract].

Sachs V, Celander DR, Szirmai E.

Folia Biol (Krakow). 1971;19(2):299-306. German. No abstract available.

PMID:
5116620
27.

Effect of an inhibitor of fibrinolysis upon the intravascular clearance of fibrin monomer in dogs.

Pratt HW 2nd, Celander DR.

J Am Osteopath Assoc. 1970 Jun;69(10):1049-50. No abstract available.

PMID:
5201432
28.

A proposed mechanism for osteopathic manipulative therapy effects on blood pressure.

Brown T, Celander E, Celander DR.

J Am Osteopath Assoc. 1970 Jun;69(10):1035-6 passim. No abstract available.

PMID:
5201424
29.

[Clinical experience and angiomyographic control with a new experimental Glutisal-buton preparation].

Szirmai E, Celander DR, Szántay J, Celnder E.

Acta Med Okayama. 1970 Jun;24(3):355-63. German. No abstract available.

PMID:
4249891
30.

[Studies of the inflammation inhibitory effect of monophenylbutazone as well as a contained active combination by Selye].

Szirmai E, Celander DR, Medgyesi G.

Pharmazie. 1969 Jun;24(6):340-1. German. No abstract available.

PMID:
5807398
31.

Preliminary results: effects of combination treatment with hydrocortisone and an antifibrinolytic agent (AMCHA) on dogs.

Steenblock DA, Fichera AP, Celander DR.

J Am Osteopath Assoc. 1969 Jun;68(10):1046. No abstract available.

PMID:
5192767
32.

Effect of osteopathic manipulative therapy on autonomic tone as evidenced by blood pressure changes and activity of the fibrinolytic system.

Fichera AP, Celander DR.

J Am Osteopath Assoc. 1969 Jun;68(10):1036-8. No abstract available.

PMID:
5192762
34.

Comparison of in vivo effects on components of the canine fibrinolytic enzyme system of AMCHA fed at varying dose levels.

Celander E, Celander DR.

Thromb Diath Haemorrh. 1968 Dec 31;20(3):547-82. No abstract available.

PMID:
5710471
35.
36.
37.

Relative effictiveness of 75Se and 125-I as lebels for rabbit anticanine urokinase.

Vigorito T, Celander DR, Celander E.

Nucl Med (Stuttg). 1968 Aug 30;7(2):136-47. No abstract available.

PMID:
4176993
38.

Properties of microsomal activator of profibrinolysin found in bovine and porcine heart muscle.

Nakahara M, Celander DR.

Thromb Diath Haemorrh. 1968 Jul 31;19(3):483-91. No abstract available.

PMID:
5708129
39.

Mechanism of in vivo incorporation into proteins of 75 Se provided as selenite.

Siew C, Sharma R, Sharma C, Celander E, Celander DR.

J Am Osteopath Assoc. 1968 May;67(9):1074. No abstract available.

PMID:
5185814
40.

Effect of aminomethylcyclohexane carboxylic acid on the behavior of erythrocytes injected intraperitoneally.

Koenig AJ, Celander DR, Pratt H Jr.

J Am Osteopath Assoc. 1968 May;67(9):1063-4. No abstract available.

PMID:
5185806
41.

Report on the effect of fibrinolytic inhibitors on guinea pig kidney tissue as revealed by electron microscopy.

Steenblock DA, Celander DR.

J Am Osteopath Assoc. 1968 May;67(9):1047-8. No abstract available.

PMID:
5185798
42.

Effect of osteopathic manipulative therapy on autonomic tone as evidenced by blood pressure changes and activity of the fibrinolytic system.

Celander E, Koenig AJ, Celander DR.

J Am Osteopath Assoc. 1968 May;67(9):1037-8. No abstract available.

PMID:
5185794
43.

[Treatment of peripheral vascular disorders, including thromboembolism and hyperlipemia, using pentose polysulfonic ester].

Szirmai E, Celander DR.

Angiologia. 1968 Mar-Apr;20(2):79-83. Spanish. No abstract available.

PMID:
5739416
44.

Characterization of fibrinolytic activity of vascular intima.

Celander DR, Celander E.

Am J Physiol. 1966 Aug;211(2):319-22. No abstract available.

PMID:
4224147
45.

FIBRINOGEN DESTRUCTION IN THE CADAVER: EFFECT OF ANTEMORTEM STRESS AND INHIBITORS.

MCKENZIE JM, CELANDER DR, GUEST MM.

Am J Physiol. 1965 May;208:1009-15. No abstract available.

PMID:
14286840
46.

IN VIVO DISTRIBUTION OF RADIOACTIVE ANTICANINE UROKINASE.

VIGORITO T, CELANDER E, MILLER A, GREEN A, SPOONHOLTZ S, GATIEN L, CELANDER DR.

J Am Osteopath Assoc. 1965 May;64:955-6. No abstract available.

PMID:
14284687
47.

IN VIVO DISTRIBUTION OF RADIOACTIVE UROKINASE.

CELANDER E, VIGORITO T, GAIL M, GORDON GA, JACQUOM JR, CELANDER DR.

J Am Osteopath Assoc. 1965 May;64:947-8. No abstract available.

PMID:
14284681
48.

Utilization of inorganic radioselenium for biosynthetic labeling of "tracer" proteins.

Celander DR, Celander E.

Tex Rep Biol Med. 1965 Fall;23(3):589-99. No abstract available.

PMID:
5846269
49.

ANTICOAGULANT THERAPY--BOON OR BANE?

CELANDER DR, CELANDER E, MARTIN CG.

J Am Osteopath Assoc. 1964 Dec;64:359-65. No abstract available.

PMID:
14233113
50.

Dietary interrelationships of ethionine in the weanling rat.

CELANDER DR, GEORGE MJ.

Biochem J. 1963 Apr;87:143-6. No abstract available.

Supplemental Content

Loading ...
Support Center